Insider filing · GLUE
Monte Rosa Therapeutics, Inc.
GLUE · Healthcare · 17 filings in 24 months
ticker →
Versant Ventures VI GP, L.P. sold $3.3M of Monte Rosa Therapeutics (GLUE)
Executed Sep 11 2024, disclosed Sep 13 2024, 2 days later.
Value, as filed
$3.3M
541,897 sh × $6.00
Executed
Sep 11 2024
the trade date, as filed
Disclosed
Sep 13 2024
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
VP
Versant Ventures VI GP, L.P.
10% owner
profile →
Versant Ventures VI GP, L.P. (10% owner) filed 1 Form 4 report as a reporting entity in the past 24 months (0 purchases, 1 sale), most often in LENZ. The largest single filing was $10.1M of LENZ (334,801 sh across 3 lots, as filed), executed Jun 18 2025.
The name
GLUEHealthcare · Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicin…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→